Cargando…
Novel COVID-19 therapies: the road ahead for rheumatology
Autor principal: | The Lancet Rheumatology |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797007/ https://www.ncbi.nlm.nih.gov/pubmed/35128471 http://dx.doi.org/10.1016/S2665-9913(22)00007-8 |
Ejemplares similares
-
Unity amidst uncertainty: COVID-19 pandemic fosters collaboration in rheumatology community
por: The Lancet Rheumatology
Publicado: (2020) -
Checking the vitals of rheumatology care in the UK
por: The Lancet Rheumatology
Publicado: (2022) -
Thank you to The Lancet Rheumatology's peer reviewers in 2022
por: The Lancet Rheumatology Editors
Publicado: (2023) -
High-stakes heterogeneity in COVID-19
por: The Lancet Rheumatology
Publicado: (2020) -
COVID-19: a time to reflect
por: The Lancet Rheumatology
Publicado: (2020)